From the Editor

Dying in America: implications for oncology of the recent IOM report


 

Those of us who work in clinical oncology are used to thinking about how to improve care for our dying patients. We may be less familiar with efforts to extend the benefits of palliative care to patients and families facing other kinds of advancing catastrophic illnesses, such as lung, cardiac, and neurologic diseases. In September last year, the Institute of Medicine of the National Academies released a report titled Dying in America: improving quality and honoring individual preferences near the end of life.1 This ambitious work encompasses the needs of all patients with potentially lethal illnesses, not just cancer.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Cancer patients with incidental VTE have high risk of recurrent thrombi
MDedge Hematology and Oncology
AI-induced symptoms don’t predict survival
MDedge Hematology and Oncology
Acupuncture beats gabapentin for hot flashes in RCT
MDedge Hematology and Oncology
Pooling knowledge to tailor an integrated delivery system
MDedge Hematology and Oncology
Predictors of resolution in navigated patients with abnormal cancer screening tests
MDedge Hematology and Oncology
Decreased weight, increased activity improved breast cancer survival for some women
MDedge Hematology and Oncology
Concomitant depression in breast cancer survivors doubles health care costs
MDedge Hematology and Oncology
Aromatase inhibitors linked to dental problems
MDedge Hematology and Oncology
Impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer
MDedge Hematology and Oncology
Management of Bleeding Complications in Patients with Cancer
MDedge Hematology and Oncology